מצגת של powerpoint -...

55

Upload: others

Post on 26-Jul-2020

0 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,
Page 2: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,
Page 3: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Yevgeni TomsovMy Dad

Page 4: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,
Page 5: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

1 million people!

Page 6: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

61 million people!

Page 7: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Page 8: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Suffer from baldness symptoms

Don't suffer

55%45%

N=470

Male pattern baldness by the age of 35

Practices

Page 9: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Effective Not effective

How effective are the solutions available?

7%

93%

N=470Practices

Page 10: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Hair tattoo

© Jill Carlson, flickr © Hagai Dekel, ynet

#trumpcat

Page 11: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

SurgicalNon-surgical

Page 12: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Non-surgical treatment

Oraldirect27.5%

Topicalindirect

28.2%Other44.3%

Relevant Research, Inc.International Society of Hair Restoration Surgery2014

Page 13: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Non-surgical treatment

Relevant Research, Inc.International Society of Hair Restoration Surgery2014

Topicalindirect

Page 14: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Non-surgical treatment

Relevant Research, Inc.International Society of Hair Restoration Surgery2014

Oraldirect Side effects

Page 15: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Testosterone Dihydrotestosterone

5α-reductase

The cause

Page 16: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Dihydrotestosterone (DHT)

©http://gondronglagi.blogspot.co.il/2013/10/ingin-gondrong-lagi.html

Page 17: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

SurgicalNon-surgical

Page 18: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

NADH/NADPH NAD+/NADP+

3α-hydroxysteroid dehydrogenase

DHT 3α-Androstanediol

Human 3-alpha hydroxysteroid ... The Journal of Steroid Biochemistry and Molecular Biology 141, 135-143.

Page 19: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Bacillus subtilis: 15.4%

The most widespread bacteria on the scalp

Secretes

Roia, F.C.; Vanderwyk, R., R. W.. Journal of The Society of Cosmetic Chemists. 1969, 20, 113-134.

Page 20: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Yes No/don’t know/other

Would balding men use a product which includes genetically modified bacteria?

22%

78%

N=470Practices

Page 21: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

NADH/NADPH NAD+/NADP+

3α-hydroxysteroid dehydrogenase

DHT 3α-Androstanediol

Human 3-alpha hydroxysteroid ... The Journal of Steroid Biochemistry and Molecular Biology 141, 135-143.

Page 22: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

For B. subtilis

Page 23: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

NADH/ NAD+/

3α-hydroxysteroid dehydrogenase

DHT 3α-Androstanediol

NADPH NADP+

Human 3-alpha hydroxysteroid ... The Journal of Steroid Biochemistry and Molecular Biology 141, 135-143.

Page 24: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.

Page 25: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.

Page 26: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.

Page 27: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.

Page 28: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.

Page 29: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

F. Canonaco, et al. FEMS Microbiology Letters 204 (2001) 247-252.

NADPH

NADPH

NADPH

NADPH

NADPH

NADPH

NADPH

Page 30: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

For BL21

For MG1655

Page 31: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Page 32: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Practices

For MG1655

For B. subtilis

Page 33: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Secretion Assay Principle

MIT OpenCourseWare

evrogen.com

Page 34: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Secretion with signal peptide aprE from B. subtilis

200

400

600

800

1000

1200

1400

1600

1800

2000

0 1 2 3 4 5 6

No

rmalized

flu

ore

scen

ce (

a.u

.)

Time (hour)

mCherry signal peptide+mCherry

BBa_K1674000

Page 35: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Activity assay principle

MIT OpenCourseWare

George H. Patterson et al. PNAS 2000;97:5203-5207

In silico model:

Page 36: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Activity of 3αHSD in E. coli BL21 lysate, DHT=40 µM

6000

8000

10000

12000

14000

16000

18000

30 300

Flu

ore

sc

en

ce

(a

.u.)

Time (min)

3αHSD no 3αHSD

BBa_K1674001

In silico model:

Page 37: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Practices

Reaction rate of NADPH consumption in different DHT concentrations

0.26

0.28

0.3

0.32

0.34

0.36

0.38

0.4

0 20 40 60 80

Reacti

on

Rate

(1

/se

c)

DHT (µM)

3αHSD no 3αHSD

BBa_K1674001

In silico model:

Page 38: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Cofactor assay principle

Extracellular Intracellular

MIT OpenCourseWare

Page 39: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Practices

Normalized NADPH fluorescence vs. Time for E. coli BL21 strains

BBa_K1674004

0

10000

20000

30000

40000

50000

60000

70000

0 4 8 12 16 20 24

Flu

ore

sc

en

ce

/OD

(a.u

.)

Time (hour)

BL21 wildtype BL21 with zwf

0

5000

10000

15000

20000

25000

30000

35000

Flu

ore

scen

ce/O

D (

a.u

.)

BL21 wildtype BL21 with zwf

Page 40: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Combined experiment principle

ExtracellularIntracellular

MIT OpenCourseWare

Page 41: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Practices

Reaction rate of consumption of NADPH from enriched supernatant

0.1

0.11

0.12

0.13

0.14

0.15

0.16

0.17

0.18

0.19

3αHSD no 3αHSD

Re

acti

on

Rat

e (

1/s

ec)

Combined experiment

BBa_K1674001 BBa_K1674004

Page 42: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

?

Page 43: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Clean

Uniform applicationSafe

Reusable

The CombDesign

Page 44: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Page 45: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Page 46: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Page 47: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Page 48: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Optimal storage conditions:-18°C in 80% glycerol medium

Practices

Page 49: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Bald DHT Chassis Cofactor Results Comb Vision

Page 50: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Benefits of our solution

Bald DHT Chassis Cofactor Results Comb Vision

Purified enzyme solution vs.bacterial secretion

NADPH User experience

Page 51: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Achievements

New Application BioBricks Design

Modeling Collaboration Practices

Page 52: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,

Our Mentors:Dr. Roee AmitDr. Orna AtarNoa KatzInbal VakninLior LevyAlex Ereskovsky

Page 53: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,
Page 54: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,
Page 55: מצגת של PowerPoint - 2015.igem.org2015.igem.org/files/presentation/Technion_Israel.pdfNon-surgical treatment Oral direct 27.5% Topical indirect Other 28.2% 44.3% Relevant Research,